WHO International Standard for anti-SARS-CoV-2 immunoglobulin

Lancet. 2021 Apr 10;397(10282):1347-1348. doi: 10.1016/S0140-6736(21)00527-4. Epub 2021 Mar 23.

Authors

Paul A Kristiansen¹, Mark Page², Valentina Bernasconi¹, Giada Mattiuzzo², Peter Dull³, Karen Makar³, Stanley Plotkin⁴, Ivana Knezevic⁵

Affiliations

¹ Coalition for Epidemic Preparedness Innovations, Oslo, Norway.
² National Institute for Biological Standards and Control, Potters Bar, UK.
³ Bill & Melinda Gates Foundation, Seattle, WA, USA.
⁴ University of Pennsylvania, Philadelphia, PA, USA.
⁵ WHO, Geneva 1211, Switzerland. Electronic address: knezevici@who.int.

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Viral / blood*
COVID-19 Vaccines / standards*
Humans
Immunoglobulins / blood*
Reference Standards
SARS-CoV-2 / immunology*
Sensitivity and Specificity
World Health Organization

Substances

Antibodies, Viral
COVID-19 Vaccines
Immunoglobulins

Grants and funding

001/WHO_/World Health Organization/International